← Eichor
Condition: Severe Hemophilia A With Inhibitor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Severe Hemophilia A With Inhibitor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
Phase N/A · 1 location(s) · Christoph Königs · NCT05802836Pharmacokinetic-guided Dosing of Emicizumab
Phase 4 · 8 location(s) · Kathelijn Fischer · NCT06320626A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A
Phase N/A · 1 location(s) · Tri-Service General Hospital (TSGH) · NCT05981274Multidimensional Assessment of Chronic Pain in Severe Haemophilia A
Phase N/A · 1 location(s) · Investigación en Hemofilia y Fisioterapia · NCT07096349A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Phase 3 · 34 location(s) · Pfizer · NCT05611801Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Phase 3 · 75 location(s) · Pfizer · NCT05145127
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.